Päivi Östling

Karolinska Institutet

Scientific Lead for Precision Medicine at SciLifeLab

Keywords
Key Publications
Mou T, Pawitan Y, Stahl M, Vesterlund M, Deng Wj, Jafari R, Bohlin A, Osterroos A, Siavelis L, Backvall H, Erkers T, Kiviluoto S, Seashore-ludlow B, Ostling P, Orre Lm, Kallioniemi O, Lehmann S, Lehtio J, Vu Tn
AMERICAN JOURNAL OF HEMATOLOGY 2021;96(5):580-588

Kaipio K, Chen P, Roering P, Huhtinen K, Mikkonen P, Ostling P, Lehtinen L, Mansuri N, Korpela T, Potdar S, Hynninen J, Auranen A, Grenman S, Wennerberg K, Hautaniemi S, Carpen O
JOURNAL OF PATHOLOGY 2020;250(2):159-169

Potdar S, Ianevski A, Mpindi Jp, Bychkov D, Fiere C, Ianevski P, Yadav B, Wennerberg K, Aittokallio T, Kallioniemi O, Saarela J, Östling P
Bioinformatics (Oxford, England) 2020;36(11):3602-3604

Saeed K, Ojamies P, Pellinen T, Eldfors S, Turkki R, Lundin J, Järvinen P, Nisen H, Taari K, Af Hällström Tm, Rannikko A, Mirtti T, Kallioniemi O, Östling P
International journal of cancer 2019;144(6):1356-1366

About me

I specialise in precision cancer medicine at SciLifeLab and the Department of Oncology-Pathology at Karolinska Institutet (KI). My work focuses on individualised drug profiling and spatial mapping of bladder cancer, in collaboration with Anders Ullén (K and KI OnkPat), Charlotte Stadler (KTH and Spatial Biology unit SciLifeLab), as well as the Olli Kallioniemi research group (KI OnkPat). Since the pandemic, I have also been involved in drug repurposing for infectious diseases with the Remedi4All consortium. As co-lead of the PCM Program at KI, I aim to accelerate the implementation of precision cancer medicine (PCM) and foster cross-disciplinary exchange. I co-organize a national PCM course for MD-PhD students, showcasing SciLifeLab technologies, clinical examples, and early clinical trial concepts. This course emphasises the importance of multidisciplinary teams in PCM research. As the Scientific Lead of Precision Medicine at SciLifeLab, my role is to advance next-generation precision medicine infrastructure. I hold key positions in Swedish Life Science, including SWELifeCancer Research KIKarolinska Comprehensive Cancer Center Board, Genomic Medicine Sweden, and the PREDICT biobank. My extensive experience in research and strategic roles is invaluable for advancing precision medicine. Together with the Precision Medicine Team, I lead two major infrastructure projects: one on advancing clinical trials and the TEF-Health project, which supports Health AI providers across Europe.

Research description

My research is on precision cancer medicine in bladder cancer. The aim is to link spatial tissue maps with drug sensitivity and molecular profiles to understand treatment responses.

Last updated: 2025-04-04

Content Responsible: David Gotthold(david.gotthold@scilifelab.se)

Help Us Improve!
We want to better match our services with your needs—take our short survey and help shape SciLifeLab’s digital future. You can also join our user panel for occasional feedback opportunities and early access to new tools.
Help Us Improve!
We want to better match our services with your needs—take our short survey and help shape SciLifeLab’s digital future. You can also join our user panel for occasional feedback opportunities and early access to new tools.